Abstract
OBJECTIVE:
Necrotizing enterocolitis (NEC), a serious multisystemic inflammatory disease most commonly seen in premature neonates, is often associated with thrombocytopenia. Infants with severe forms of NEC commonly have platelet counts of less than 50,000/mm3, occasionally less than 10,000/mm3. Despite an absence of data to support the practice, platelet transfusions are commonly used to maintain a certain arbitrary platelet count in an effort to prevent bleeding. As platelet transfusions contain a variety of bioactive factors including pro-inflammatory cytokines, we hypothesized that a higher number and volume of platelet transfusions would not be associated with an improvement in mortality or morbidity.
STUDY DESIGN:
A retrospective cohort analysis was conducted of the medical records of all infants between 1997 and 2001 with Bell's Stage 2 or 3 NEC associated with platelet counts of <100,000/mm3. The medical records were evaluated for the following variables: platelet counts, number and volume of platelet transfusions, symptoms of bleeding, and hospital course. Mortality and development of short bowel syndrome and/or cholestasis were correlated to the total number and volume (total ml and ml/kg) of platelet transfusions. Differences between the outcome groups were compared using the independent t-test, Fisher's exact test and Mann–Whitney tests.
RESULTS:
A total of 46 infants met the study criteria (gestational age 28±4 weeks and birth weight 1166±756 g, mean±SD). There were a total of 406 platelet transfusions administered to the study population. Of these, 151 (37.2%) were given in the presence of active bleeding, with 62% of these resulting in the cessation of bleeding within 24 hours. Other listed indications for platelet transfusions were hypovolemia and severe thrombocytopenia. On analysis of the entire cohort, there was no statistical improvement in either mortality or morbidity (short bowel syndrome and cholestasis) with greater number and/or volume of platelet transfusions. Furthermore, we found that infants who developed short bowel syndrome and/or cholestasis had been given a significantly higher number and volume of platelet transfusions when compared to those who did not have these adverse outcomes [median (minimum – maximum)−number of transfusions : 9 (0 to 33) vs 1.5 (0 to 20), p=0.010; volume of transfusions (ml/kg) : 121.5 (0 to 476.6) vs 33.2 (0 to 224.3), p=0.013].
CONCLUSION:
This retrospective analysis suggests that greater number and volume of platelet transfusions in infants with necrotizing enterocolitis are associated with greater morbidity in the form of short bowel syndrome and/or cholestasis without the benefit of lower mortality.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Uhrynowska M, Niznikowska-Marks M, Zupanska B . Neonatal and maternal thrombocytopenia: incidence and immune background. Eur J Haematol 2000;64 (1):42–46.
Murray NA, Howarth LJ, McCloy MP, Letsky EA, Roberts IA . Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 2002;12 (1):35–41.
Murray NA . Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 2002;91 (438):74–81.
Roberts IA, Murray NA . Thrombocytopenia in the newborn. Curr Opin Pediatr 2003;15 (1):17–23.
Ververidis M, Kiely EM, Spitz L, Drake DP, Eaton S, Pierro A . The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis. J Pediatr Surg 2001;36 (5):799–803.
Hutter Jr JJ, Hathaway WE, Wayne ER . Hematologic abnormalities in severe neonatal necrotizing enterocolitis. J Pediatr 1976;88 (6):1026–1031.
Ragazzi S, Pierro A, Peters M, Fasoli L, Eaton S . Early full blood count and severity of disease in neonates with necrotizing enterocolitis. Pediatr Surg Int 2003;19 (5):376–379.
Andrew M, Vegh P, Caco C, et al. A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123 (2):285–291.
Rebulla P . Platelet transfusion trigger in difficult patients. Transfus Clin Biol 2001;8 (3):249–254.
Murray NA, Roberts IA . Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004;89 (2):F101–F107.
Garcia MG, Duenas E, Sola MC, Hutson AD, Theriaque D, Christensen RD . Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001; 21 (7):415–420.
Larsson LG, Welsh VJ, Ladd DJ . Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40 (8):902–906.
Kluter H, Bubel S, Kirchner H, Wilhelm D . Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999;39 (11–12):1179–1184.
Blajchman MA, Ali AM, Richardson HL . Bacterial contamination of cellular blood components. Vox Sang 1994;67(Suppl 3):25–33.
Kopko PM, Fernando LP, Bonney EN, Freeman JL, Holland PV . HIV transmissions from a window-period platelet donation. Am J Clin Pathol 2001;116 (4):562–566.
Kleinman S, Chan P, Robillard P . Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003;17 (2):120–162.
Bell CE, Botteman MF, Gao X, et al. Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States. Clin Ther 2003;25 (9):2464–2486.
Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F . Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003;6 (1):6–23.
Kling PJ, Hutter JJ . Hematologic abnormalities in severe neonatal necrotizing enterocolitis: 25 years later. J Perinatol 2003;23 (7):523–530.
Qu XW, Rozenfeld RA, Huang W, Bulkley GB, Hsueh W . The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat. Gut 1999;44 (2):203–211.
Zhang C, Hsueh W, Caplan MS, Kelly A . Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 1991;19 (8):1067–1072.
Edvardsen L, Taaning E, Mynster T, Hvolris J, Drachman O, Nielsen HJ . Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions. Br J Haematol 1998;103 (2):445–448.
Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003;43 (5):633–640.
Kahn DJ, Richardson DK, Billett HH . Inter-NICU variation in rates and management of thrombocytopenia among very low birth-weight infants. J Perinatol 2003;23 (4):312–316.
Snyder F . Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990;259 (5 Part 1):C697–C708.
Denizot Y, Dassa E, Benveniste J, Thomas Y . Paf-acether production by Escherichia coli. Biochem Biophys Res Commun 1989;161 (2):939–943.
Stohlawetz P, Folman CC, von dem Borne AE, et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 1999;81 (4):613–617.
McGuire W, Anthony MY . Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed 2003;88 (1):F11–F14.
Furukawa M, Lee EL, Johnston JM . Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatr Res 1993;34 (2):237–241.
Moya FR, Eguchi H, Zhao B, et al. Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report. J Pediatr Gastroenterol Nutr 1994;19 (2):236–239.
Furukawa M, Narahara H, Yasuda K, Johnston JM . Presence of platelet-activating factor-acetylhydrolase in milk. J Lipid Res 1993;34 (9):1603–1609.
O'Donovan DJ, Baetiong A, Adams K, et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol 2003;23 (4):286–290.
Cooke L, Steer P, Woodgate P . Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database System Review 2003; (2):CD003745.
Fowlie PW, Davis PG . Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003;88 (6):F464–F466.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kenton, A., Hegemier, S., Smith, E. et al. Platelet Transfusions in Infants with Necrotizing Enterocolitis Do Not Lower Mortality but May Increase Morbidity. J Perinatol 25, 173–177 (2005). https://doi.org/10.1038/sj.jp.7211237
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211237
This article is cited by
-
Role of platelets in neonatal necrotizing enterocolitis
Pediatric Research (2021)
-
Implementation of a neonatal platelet transfusion guideline to reduce non-indicated transfusions using a quality improvement framework
Journal of Perinatology (2021)
-
Hematological predictors of mortality in neonates with fulminant necrotizing enterocolitis
Journal of Perinatology (2021)
-
Fresh Frozen Plasma and Platelet Transfusion Practices in Neonatal Intensive Care Unit of a Tertiary Care Hospital
Indian Journal of Hematology and Blood Transfusion (2020)
-
Outcomes after implementing restrictive blood transfusion criteria in extremely premature infants
Journal of Perinatology (2019)